The purpose of the project is to investigate the biological roles of members of the chemokine family of cytokines by studying chemokine actions in vivo, particularly in mouse models of infectious disease, inflammation, and angiogenesis. These experiments will provide important information for understanding in which therapeutic contexts in humans manipulating the chemokine system might be beneficial. This laboratory discovered two mouse chemokines, Crg-2 and Mig. Crg-2 is the mouse homologue of the human chemokine IP-10, and the murine Mig (MuMig) was used to identify a human homologue, HuMig. Crg-2/IP-10 and Mig are related interferon-gamma inducible chemokines that preferentially target lymphocytes, acting as chemotactic factors for activated T cells and natural killer cells. It is our hypothesis that these chemokines are important for recruiting T cells to sites of inflammation and immune response. In addition to studying Mig and Crg-2/IP-10, for a number of in vivo models the project will include a systematic evaluation of the expression of multiple chemokines in order to develop a more comprehensive understanding of the roles for chemokines in these reactions and to identify which are likely to be of principle importance within a particular context. The project has involved analyzing chemokine expression in the infections of mice with the protozoan pathogens Toxoplasma gondii and Plasmodium yoellii, the trematode pathogen Schistosoma mansoni, vaccinia virus, and the opportunistic bacterial pathogen Mycobacterium avium. Mice have been derived with targeted disruption of the mig gene and neutralizing antibodies have been raised against Mig as well as Crg-2/IP-10. In addition to most of the experimental infections listed above, the mice lacking Mig have been analyzed after infections with listeria, salmonella, and francisella bacteria, ectromelia virus, and the fungal pathogen cryptococcus. These mice are also being evaluated for their inflammatory responses in delayed- type hypersensitivity and in contact hypersensitivity. In related experiments, recombinant vaccinia virus have been made expressing Mig and Crg-2/IP-10, and the effects of viral production of these chemokines is being analyzed during infections of mice having a variety of defined immunodeficiencies. Finally, the project involves experiments on the ability of Mig and Crg-2/IP-10 to inhibit angiogenesis, particularly in tumor growth. Evaluation of models of infection and inflammation includes monitoring mortality and other clinical parameters, titering of organisms recovered from infected mice, analysis of immune/inflammatory responses in tissues by quantifying expression of chemokine and chemokine mRNAs and by histology, in situ hybridization, immunohistochemistry, and flow cytometry, and analysis of other aspects of immune response by determining antibody production and production of cytokines after in vitro restimulation of cells isolated from infected animals. Evaluation in models of angiogenesis involves quatification of new blood vessel and tumor growth.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000725-04
Application #
6099049
Study Section
Special Emphasis Panel (LCI)
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Hedrick, Michael N; Lonsdorf, Anke S; Shirakawa, Aiko-Konno et al. (2009) CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J Clin Invest 119:2317-29
Cortes, Lizette M; Mattapallil, Mary J; Silver, Phyllis B et al. (2008) Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice. Invest Ophthalmol Vis Sci 49:1946-56
Gorbachev, Anton V; Kobayashi, Hirohito; Kudo, Daisuke et al. (2007) CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors. J Immunol 178:2278-86
Barlic, Jana; Zhang, Yuan; Foley, John F et al. (2006) Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway. Circulation 114:807-19
Wuest, Todd; Farber, Joshua; Luster, Andrew et al. (2006) CD4+ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection. Cell Immunol 243:83-9
Wald, Ori; Weiss, Ido D; Wald, Hanna et al. (2006) IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organs. J Immunol 176:4716-29
Medoff, Benjamin D; Wain, John C; Seung, Edward et al. (2006) CXCR3 and its ligands in a murine model of obliterative bronchiolitis: regulation and function. J Immunol 176:7087-95
Fulkerson, Patricia C; Zimmermann, Nives; Brandt, Eric B et al. (2004) Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-gamma (Mig, CXCL9). Proc Natl Acad Sci U S A 101:1987-92
Park, Matthew K; Amichay, Doron; Love, Paul et al. (2002) The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. J Immunol 169:1433-43
Uehara, Shoji; Song, Kaimei; Farber, Joshua M et al. (2002) Characterization of CCR9 expression and CCL25/thymus-expressed chemokine responsiveness during T cell development: CD3(high)CD69+ thymocytes and gammadeltaTCR+ thymocytes preferentially respond to CCL25. J Immunol 168:134-42

Showing the most recent 10 out of 15 publications